Dr A.F.G. Leentjens

Leentjens, A. F. G., & Pontone, G. M. (2026). Perspective: Depression in Persons with Parkinson's Disease. Movement Disorders, 41(6), 1355-1361. https://doi.org/10.1002/mds.70285

Betrouni, N., Derambure, P., Defebvre, L., Leentjens, A. F. G., Delval, A., & Dujardin, K. (2026). Electroencephalography microstates detect early cognitive impairment in Parkinson's disease. Parkinsonism & Related Disorders, 146, Article 108280. https://doi.org/10.1016/j.parkreldis.2026.108280

van Lier, M., Carey, G., Viard, R., Kuijf, M. L., Wolters, A. F., Dujardin, K., & Leentjens, A. F. (2025). Cortical thickness alterations in Parkinson's disease related anxiety: A cross-sectional 7 T MRI study. Journal of Parkinsons Disease, 15(8), 1513-1523. Article 1877718251367302. https://doi.org/10.1177/1877718X251367302

Sisodia, V., Swinnen, B. E. K. S., Lemstra, E., Geurtsen, G. J., Leentjens, A. F. G., Buijsen, M. A. J. M., Schermer, M. H. N., & de Bie, R. M. A. (2025). Informed Consent Procedure for Research Including Patients with Parkinson's Disease and Cognitive Impairment. Movement Disorders Clinical Practice, 12(10), 1507-1510. https://doi.org/10.1002/mdc3.70174

Andriessen, R. L., Oosterloo, M., Molema, J., Daemen, M. M. J., Linden, D. E. J., & Leentjens, A. F. G. (2025). Pharmacological Treatment of Neuropsychiatric Symptoms in Huntington's Disease: A Systematic Review. Movement Disorders Clinical Practice, 12(4), 418-431. https://doi.org/10.1002/mdc3.14343

Carey, G., Kuijf, M. L., Michielse, S., Wolters, A. F., Dujardin, K., & Leentjens, A. F. (2025). Reduced volume of the mediodorsal and anteroventral thalamus is associated with anxiety in Parkinson's disease: A cross-sectional 7-tesla MRI study. Journal of Parkinsons Disease, 15(2), 338–348. https://doi.org/10.1177/1877718X241308141

Postuma, R. B., Weintraub, D., Simuni, T., Rodriguez-Violante, M., Leentjens, A. F. G., Hu, M. T., Espay, A. J., Erro, R., Dujardin, K., Bohnen, N. I., Berg, D., Mestre, T. A., & Marras, C. (2024). Anticipating Tomorrow: Tailoring Parkinson's Symptomatic Therapy Using Predictors of Outcome. Movement Disorders Clinical Practice, 11(8), 983-991. https://doi.org/10.1002/mdc3.14089

Meyer, G. M., Hollunder, B., Li, N., Butenko, K., Dembek, T. A., Hart, L., Nombela, C., Mosley, P., Akram, H., Acevedo, N., Borron, B. M., Chou, T., Castaño Montoya, J. P., Strange, B., Barcia, J. A., Tyagi, H., Castle, D. J., Smith, A. H., Choi, K. S., ... Horn, A. (2024). Deep Brain Stimulation for Obsessive-Compulsive Disorder: Optimal stimulation sites. Biological Psychiatry, 96(2), 101-113. https://doi.org/10.1016/j.biopsych.2023.12.010

Marras, C., Fereshtehnejad, S.-M., Berg, D., Bohnen, N. I., Dujardin, K., Erro, R., Espay, A. J., Halliday, G., Van Hilten, J. J., Hu, M. T., Jeon, B., Klein, C., Leentjens, A. F. G., Mollenhauer, B., Postuma, R. B., Rodriguez-Violante, M., Simuni, T., Weintraub, D., Lawton, M., & Mestre, T. A. (2024). Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven Approach. Movement Disorders, 39(3), 462-471. https://doi.org/10.1002/mds.29708